Fecal Calprotectin: The Simple Stool Test That Can Spare You a Colonoscopy

What Calprotectin Actually Is (and Why It Ends Up in Your Stool)

Calprotectin is a protein that binds calcium and zinc, formally known as S100A8/S100A9. It makes up a large share of the cytosolic protein inside neutrophils, the white blood cells that rush to sites of inflammation as part of your innate immune response.

When your intestinal lining is inflamed, neutrophils migrate into the gut wall and lumen, releasing calprotectin in the process. The protein is remarkably stable once it hits your stool, which is one reason it works so well as a biomarker. Stool concentrations run roughly six times higher than blood levels, making a stool sample far more informative than a blood draw for detecting gut-specific inflammation.

Calprotectin isn't just a passive bystander. It actively participates in innate immunity, chelates metals away from pathogens, has direct antimicrobial activity, and helps modulate inflammatory pathways in the gut. It's both a signal and a player.

The Test's Strongest Suit: Sorting IBS From IBD

The most validated use of fecal calprotectin is answering a deceptively tricky clinical question: are your gut symptoms caused by inflammation, or by a functional disorder like IBS?

This matters because IBS and IBD can look remarkably similar on the surface. Both cause abdominal pain, diarrhea, urgency, and bloating. But IBD involves actual mucosal damage that needs specific treatment, while IBS does not. Historically, the only way to tell them apart definitively was endoscopy.

Fecal calprotectin changes that calculus:

• High levels strongly support IBD or another organic inflammatory process, warranting further workup.
• Normal levels carry excellent negative predictive value for IBD, meaning the test is very good at telling you when inflammation isn't present, potentially sparing you an invasive procedure.

This makes it especially useful as a first-line triage tool for symptomatic patients before committing to colonoscopy.

Beyond Diagnosis: Tracking IBD Over Time

For people already diagnosed with IBD, fecal calprotectin shifts from a screening tool to a monitoring tool. Its levels correlate with endoscopic and histologic inflammation, meaning it can reflect what's actually happening at the mucosal surface without requiring a scope every time.

This has several practical applications:

The ability to track disease activity through a stool sample rather than repeated colonoscopies is a meaningful quality-of-life advantage. It doesn't replace endoscopy entirely, but it reduces how often you need one.

When a High Result Doesn't Mean IBD

Here's where interpretation gets tricky. Fecal calprotectin is sensitive to intestinal inflammation, but it is not specific to any single disease. A high result doesn't automatically mean IBD. Levels also rise in:

• Colorectal cancer
• Infectious enteritis
• Celiac disease
• Diverticular disease
• Regular use of NSAIDs (like ibuprofen) or PPIs (acid-reducing medications like omeprazole)
• Other inflammatory conditions affecting the gut

This means an elevated result always needs clinical context. Your doctor has to weigh the number against your symptoms, medication use, age, and the broader picture. A mildly elevated fecal calprotectin in someone taking daily ibuprofen tells a very different story than the same number in someone with bloody diarrhea.

The Cut-Off Problem

One of the ongoing challenges with fecal calprotectin is that there's no single universally agreed-upon threshold separating "normal" from "abnormal." Optimal cut-off values vary depending on:

• Which assay (brand/method) your lab uses
• Your age
• The specific clinical question being asked (screening for IBD vs. defining mucosal healing vs. predicting relapse)

This means the same numerical result could be interpreted differently depending on the context. The thresholds for distinguishing IBS from IBD aren't necessarily the same thresholds used to define mucosal healing in a Crohn's disease patient on biologic therapy. That debate is still active.

There's also a technical gap worth noting. Standard assays may miss certain forms of the protein, specifically S100A8/A9 homodimers, that can be elevated and biologically active in IBD. This means a "normal" fecal calprotectin result could, in rare cases, coexist with active disease driven by these subtypes that the test doesn't fully capture.

How to Think About Your Results

Fecal calprotectin is best understood as a powerful but imperfect filter. It excels at two things: ruling out IBD when levels are normal, and tracking mucosal inflammation over time in people who already have IBD. It is not a standalone diagnostic test, and it was never designed to be one.

If your result comes back:

• Normal: Strong evidence against active intestinal inflammation. If IBD was the concern, this is genuinely reassuring and may mean you can avoid colonoscopy.
• Elevated: Something is inflaming your gut, but the test alone can't tell you what. Further investigation, including clinical context, medication review, and potentially endoscopy, is the next step.
• Borderline: This is where clinical judgment matters most. Repeat testing, symptom tracking, and your doctor's overall assessment of your situation will drive the decision.

The test works best as part of a conversation, not as a verdict. But for millions of people caught between uncertain gut symptoms and an invasive procedure, it remains one of the most useful non-invasive tools gastroenterology has.